The DOI matches its Crossref record; 156 of the 157 references it cites were found in a registry or an index.
Parkinson's disease: clinical features and diagnosis
Open accessAbstract
OBJECTIVE: Parkinson's disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review describes the clinical characteristics of PD with emphasis on those features that differentiate the disease from other parkinsonian disorders. METHODS: A MedLine search was performed to identify studies that assess the clinical characteristics of PD. Search terms included "Parkinson's disease", "diagnosis" and "signs and symptoms". RESULTS: Because there is no definitive test for the diagnosis of PD, the disease must be diagnosed based on clinical criteria. Rest tremor, bradykinesia, rigidity and loss of postural reflexes are generally considered the cardinal signs of PD. The presence and specific presentation of these features are used to differentiate PD from related parkinsonian disorders. Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain). Absence of rest tremor, early occurrence of gait difficulty, postural instability, dementia, hallucinations, and the presence of dysautonomia, ophthalmoparesis, ataxia and other atypical features, coupled with poor or no response to levodopa, suggest diagnoses other than PD. CONCLUSIONS: A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease. Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most medical diagnoses rely on standardized guidelines [23, 26, 60].”
From Understanding the Effect of Counterfactual Explanations on Trust and Reliance on AI for Human-AI Collaborative Clinical Decision Making (2023) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resting tremor that occurs in a fully supported arm serves as an important symptom in differentiating PD from ET in clinical diagnosis (Jankovic, 2008).”
From A Novel Posture for Better Differentiation Between Parkinson's Tremor and Essential Tremor (2018) · cites this paper as Jankovic, 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Around 80% have limb tremor, most commonly a resting pill-rolling type of tremor of the hands.”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Jankovic 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Dopamine neuron systems in the brain: An update
Björklund, A., & Dunnett, S. B. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.006 · Cited by 1,777
Goetz, C. G., Fahn, S., Martínez‐Martín, P., Poewe, W. H., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R. C., Dubois, B., et al. (2006) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,443
Self-citationHughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
Bloem, B. R., Hausdorff, J. M., Visser, J. E., & Giladi, N. (2004) · Movement Disorders · doi:10.1002/mds.20115 · Cited by 1,298
Modification of Parkinsonism — Chronic Treatment with L-Dopa
Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. A. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,287
Schenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Flagged first, then by citations
1 of the 157 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- [41]41. Stamey WP, Jankovic J. Shoulder pain in Parkinson's disease. Mov Disord 2007;22:S247-8.
- [50]50. Djaldetti R, Mosberg-Galili R, Sroka H, et al. Camptocormia (bent spine) in patients with Parkinson's disease-characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 1999;14:443-7.
- [53]53. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem- confirmed parkinsonian disorders. Mov Disord 1999;14:947-50.
- [57]57. Koller WC, Glatt S, Vetere-Overfield B, et al. Falls and Parkinson's disease. Clin Neuropharmacol 1989;12:98-105.
- [68]68. Marchese R, Diverio M, Zucchi F, et al. The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord 2000;15:879-83.
- [75]75. Wu J, Sitburana O, Jankovic J. The specificity and sensitivity of ''applause sign'' in differentiating PSP and other parkinsonian syndromes. Mov Disord 2007;22:S254-5.
Cited by
Sorted by citations
Items 301–400 of 1,030
Aquatic Exercise Therapy for People With Parkinson Disease: A Randomized Controlled Trial
Carroll, L. M., Volpe, D., Morris, M. E., Saunders, J. A., & Clifford, A. M. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.12.006 · Cited by 122
Adams, W. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188226 · Cited by 123
Hassanzadeh, K., & Rahimmi, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26865 · Cited by 126
The neuroscience of sadness: A multidisciplinary synthesis and collaborative review
Arias-López, J. A., Williams, C., Raghvani, R., Aghajani, M., Báez, S., Belzung, C., Booij, L., Busatto, G. F., Chiarella, J., Fu, C. H. Y., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.006 · Cited by 138
Parkinson’s disease: a review of non-motor symptoms
Rana, A. Q., Ahmed, U. S., Chaudry, Z. M., & Vasan, S. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1038244 · Cited by 122
“It is possible that olfactory dysfunction may be related to loss of neurons in the corticomedial amygdala or to the decrease of dopaminergic neurons in the olfactory bulb [86].”
Gürüler, H. (2016) · Neural Computing and Applications · doi:10.1007/s00521-015-2142-2 · Cited by 121
Animal models of Parkinson's disease: An updated overview
Gubellini, P., & Kachidian, P. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.011 · Cited by 128
Dudzik, C. G., Walter, É., & Millhauser, G. L. (2011) · Biochemistry · doi:10.1021/bi101912q · Cited by 120
Samà, A., Pérez‐López, C., Rodríguez-Martín, D., Catalá, A., Aróstegui, J. M. M., Cabestany, J., de Mingo-Fernández, E., & Rodríguez‐Molinero, A. (2017) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2017.03.020 · Cited by 120
Chen, J. J. (2010) · PubMed · Cited by 120
Dynamic mesolimbic dopamine signaling during action sequence learning and expectation violation
Collins, A. L., Greenfield, V. Y., Bye, J. K., Linker, K. E., Wang, A. S., & Wassum, K. M. (2016) · Scientific Reports · doi:10.1038/srep20231 · Cited by 125
Vermeiren, Y., & Deyn, P. P. D. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.11.009 · Cited by 119
Gündüz, H. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102452 · Cited by 119
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Streubel-Gallasch, L., Giusti, V., Sandre, M., Tessari, I., Plotegher, N., Giusto, E., Masato, A., Iovino, L., Battisti, I., Arrigoni, G., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02327-8 · Cited by 100
Protein Misfolding and Aggregation in Parkinson's Disease
Tan, J. M. M., Wong, E. S. P., & Lim, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2490 · Cited by 121
Electrophysiology and Optical Coherence Tomography to Evaluate Parkinson Disease Severity
García‐Martín, E., Mena, D. R., Satué, M., Almárcegui, C., Dolz, I., Alarcia, R., Seral, M., Polo, V., Larrosa, J. M., & Pablo, L. E. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13062 · Cited by 127
García‐Martín, E., Satué, M., Fuertes, I., Otín, S., Alarcia, R., Herrero, R., BAMBO, M., Fernández, J., & Pablo, L. E. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.003 · Cited by 118
Parkinson's disease classification using gait analysis via deterministic learning
Zeng, W., Liu, F., Wang, Q., Wang, Y., Ma, L., & Zhang, Y. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.043 · Cited by 118
The study of brain functional connectivity in Parkinson’s disease
Gao, L., & Wu, T. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0066-0 · Cited by 118
“inclusions composed of α-synuclein aggregates known as Lewy bodies [1].”
BackgroundDifferential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Caggiu, E., Paulus, K. S., Mameli, G., Arru, G., Sechi, G., & Sechi, L. A. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.09.002 · Cited by 119
“Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons, causing symptoms such as muscle rigidity, resting tremor, bradykinesia, and postural instability [1].”
BackgroundHussain, G., Huang, J. D., Rasul, A., Anwar, H., Imran, A., Maqbool, J., Razzaq, A., Aziz, N., Makhdoom, E. U. H., Konuk, M., et al. (2019) · Molecules · doi:10.3390/molecules24122213 · Cited by 118
The Therapeutic Role of Ketogenic Diet in Neurological Disorders
Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska‐Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 136
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104593 · Cited by 115
Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 129
Olfactory dysfunction as a diagnostic marker for Parkinson’s disease
Haehner, A., Hummel, T. R., & Reichmann, H. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.115 · Cited by 116
Discriminating Between Patients With Parkinson’s and Neurological Diseases Using Cepstral Analysis
Benba, A., Jilbab, A., & Hammouch, A. (2016) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2016.2533582 · Cited by 115
Epigenetic regulation in Parkinson’s disease
Labbé, C., Lorenzo‐Betancor, O., & Ross, O. A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1590-9 · Cited by 118
Pharmacological Treatment of Parkinson’s Disease
Zahoor, I., Shafi, A., & Haq, E. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch7 · Cited by 120
Herman, T., Weiss, A., Brozgol, M., Giladi, N., & Hausdorff, J. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7513-6 · Cited by 115
“Parkinson’s disease (PD) is a progressive neurodegenerative synucleinopathy, manifested by a broad spectrum of motor and non-motor symptoms [1].”
BackgroundVocal Responses to Perturbations in Voice Auditory Feedback in Individuals with Parkinson's Disease
Liu, H., Wang, E. Q., Metman, L. V., & Larson, C. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033629 · Cited by 114
“The cardinal symptoms of PD include resting tremor, rigidity, bradykinesia and postural instability [1,2].”
Du, G., Liu, X., Chen, X., Song, M. L., Yan, Y., Jiao, R., & Wang, C.-C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0200 · Cited by 116
Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
Salim, S., Ahmad, F. A., Banu, A., & Mohammad, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.10.013 · Cited by 124
Heuer, A., Smith, G. A., Lelos, M. J., Lane, E. L., & Dunnett, S. B. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.027 · Cited by 114
Hoban, D. B., Connaughton, E., Connaughton, C., Hogan, G., Thornton, C., Mulcahy, P. J., Moloney, T. C., & Dowd, E. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.10.001 · Cited by 114
Chen, Y., Wang, L., Qin, X., Wang, J., & Xie, X. (2023) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2023.3297103 · Cited by 127
Near‐infrared light is neuroprotective in a monkey model of Parkinson disease
Darlot, F., Moro, C., El Massri, N., Chabrol, C., Johnstone, D. M., Reinhart, F., Agay, D., Torres, N., Bekha, D., Auboiroux, V., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24542 · Cited by 114
Non‐motor Parkinson disease: new concepts and personalised management
Titova, N., & Chaudhuri, К. R. (2018) · The Medical Journal of Australia · doi:10.5694/mja17.00993 · Cited by 112
Mice Lacking Major Brain Gangliosides Develop Parkinsonism
Wu, G., Lu, Z., Kulkarni, N., Amin, R. K., & Ledeen, R. W. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0437-y · Cited by 112
“It is a progressive neurodegenerative disease characterized by resting tremor, postural rigidity, bradykinesia, autonomic instability and in its later stages by cognitive and emotional disorders [23, 24].”
BackgroundThe chemistry and biological potential of azetidin-2-ones
Arya, N., Jagdale, A. Y., Patil, T. A., Yeramwar, S. S., Holikatti, S. S., Dwivedi, J., Shishoo, C. J., & Jain, K. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.002 · Cited by 112
Wassum, K. M., Ostlund, S. B., & Maidment, N. T. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.019 · Cited by 119
Elefant, C., Baker, F. A., Lotan, M., Lagesen, S. K., & SKEIE, G. O. (2012) · Journal of Music Therapy · doi:10.1093/jmt/49.3.278 · Cited by 111
Shin, S., Burnett, R. T., Kwong, J. C., Hystad, P., van Donkelaar, A., Brook, J. R., Copes, R., Tu, K., Goldberg, M. S., Villeneuve, P. J., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy172 · Cited by 111
α-Synuclein modulates tau spreading in mouse brains
Bassil, F., Meymand, E. S., Brown, H. J., Xu, H. W., Cox, T. O., Pattabhiraman, S., Maghames, C. M., Wu, Q., Zhang, B., Trojanowski, J. Q., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192193 · Cited by 109
“…unique pathological proteins in the brain, including pathological α-synuclein (α-syn) proteins in Lewy bodies in Parkinson’s disease (PD) and hyperphosphorylated tau (p-tau) in neurofibrillary tangles in Alzheimer’s disease (AD; Galasko et al., 1994; Jankovic, 2008; Spillantini and Goedert, 2016).”
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Feng, Y., & Lü, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663102 · Cited by 113
Structural and Functional Insights into α-Synuclein Fibril Polymorphism
Mehra, S., Gadhe, L. G., Bera, R., Sawner, A. S., & Maji, S. K. (2021) · Biomolecules · doi:10.3390/biom11101419 · Cited by 111
“Four cardinal symptoms, such as bradykinesia, resting tremor, postural instability, and rigidity are considered for clinical diagnosis of PD [67].”
Khatamino, P., Cantürk, İ., & Özyılmaz, L. (2018) · International Conference on Control, Engineering & Information Technology · doi:10.1109/ceit.2018.8751879 · Cited by 110
Chakraborty, S., Aich, S., Jong-Seong-Sim, Han, E., Park, J., & Kim, H. (2020) · International Conference on Advanced Communication Technology · doi:10.23919/icact48636.2020.9061497 · Cited by 110
Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases
Moreno‐García, L., López‐Royo, T., Calvo, A. C., Toivonen, J. M., de la Torre, M., Moreno‐Martínez, L., Molina, N., Aparicio, P., Zaragoza, P., Manzano, R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249582 · Cited by 111
Continuous home monitoring of Parkinson’s disease using inertial sensors: A systematic review
Sica, M., Tedesco, S. A., Crowe, C., Kenny, L., Moore, K., Timmons, S., Barton, J. J., O’Flynn, B., & Komaris, D.-S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246528 · Cited by 124
Risk Factors for Cage Retropulsion After Posterior Lumbar Interbody Fusion
Kimura, H. J., Shikata, J., Odate, S., Soeda, T., & Yamamura, S. (2012) · Spine · doi:10.1097/brs.0b013e318257f12a · Cited by 110
Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology
Wilson, T. W., Heinrichs‐Graham, E., Proskovec, A. L., & McDermott, T. J. (2016) · Translational research · doi:10.1016/j.trsl.2016.01.007 · Cited by 114
Patella, B., Sortino, A., Mazzara, F., Aiello, G., Drago, G., Torino, C., Vilasi, A. D., O'Riordan, A. J., & Inguanta, R. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339124 · Cited by 109
Ellmore, T. M., Castriotta, R. J., Hendley, K. L., Aalbers, B. M., Furr-Stimming, E. E., Hood, A. J., Suescun, J., Beurlot, M. R., Hendley, R. T., & Schiess, M. C. (2013) · SLEEP · doi:10.5665/sleep.3222 · Cited by 108
DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
Lin, X., Cook, T. J., Zabetian, C. P., Leverenz, J. B., Peskind, E. R., Hu, S., Cain, K. C., Pan, C., Edgar, J. S., Goodlett, D. R., et al. (2012) · Scientific Reports · doi:10.1038/srep00954 · Cited by 110
Disease progression in Parkinson subtypes: the PPMI dataset
Aleksovski, D., Miljković, D., Bravi, D., & Antonini, A. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3522-z · Cited by 108
Social role functioning in Parkinson's disease: A mixed‐methods systematic review
Perepezko, K. M., Hinkle, J. T., Shepard, M. D., Fischer, N. M., Broen, M. P. G., Leentjens, A. F. G., Gallo, J. J., & Pontone, G. M. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5137 · Cited by 123
Sanches, C., Stengel, C., Godard, J., Mertz, J., Teichmann, M., Migliaccio, R., & Valero‐Cabré, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.578339 · Cited by 120
Song, Q., Peng, S., & Zhu, X. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.10.003 · Cited by 108
Beuter, A., Lefaucheur, J.-P., & Modolo, J. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.01.006 · Cited by 107
Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106
“Though tremor at rest, rigidity, bradykinesia and postural instability are the key motor symptoms of PD [2], various non-motor symptoms (NMS) such as psychosis, depression, cognitive decline, autonomic disturbances, sleep disturbances may be observed during the course of illness [3,4].”
Classifying Parkinson’s Disease Based on Acoustic Measures Using Artificial Neural Networks
Berus, L., Klančnik, S., Brezočnik, M., & Ficko, M. (2018) · Sensors · doi:10.3390/s19010016 · Cited by 107
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Veys, L., Vandenabeele, M., Ortuño‐Lizarán, I., Baekelandt, V., Cuenca, N., Moons, L., & Groef, L. D. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-01956-z · Cited by 114
Shalin, G., Pardoel, S., Lemaire, E. D., Nantel, J., & Kofman, J. (2021) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-021-00958-5 · Cited by 116
Sleep and circadian rhythms in Parkinson’s disease and preclinical models
Hunt, J., Coulson, E. J., Rajnarayanan, R. V., Oster, H., Videnović, A., & Rawashdeh, O. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00504-w · Cited by 118
“PD has a clinical presentation of progressively worsening bradykinesia, typically accompanied by either gait disturbance, resting tremor or rigidity [125, 127, 128], however it is commonly accepted that PD-related neurodegeneration can begin several decades before motor symptom onset [129, 130].”
Pathogenesis of DJ-1/PARK7-Mediated Parkinson’s Disease
Skou, L. D., Johansen, S. K., Okarmus, J., & Meyer, M. (2024) · Cells · doi:10.3390/cells13040296 · Cited by 120
The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease
Tüfekçi, K. U., Genç, Ş., & Genç, K. (2011) · Parkinson s Disease · doi:10.4061/2011/487450 · Cited by 110
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103
Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 109
Towards remote monitoring of Parkinson’s disease tremor using wearable motion capture systems
Delrobaei, M., Memar, S., Pieterman, M., Stratton, T. W., McIsaac, K., & Jog, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.11.004 · Cited by 106
Hussain, G., Zhang, L., Rasul, A., Anwar, H., Sohail, M. U., Razzaq, A., Aziz, N., Shabbir, A., Ali, M. Z., & Sun, T. (2018) · Molecules · doi:10.3390/molecules23040814 · Cited by 110
Liu, W., Wei, S., Huang, G., Liu, L.-B., Gu, C., Shen, Y., Wang, X., Xia, S., Xie, A., Hu, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901565rr · Cited by 107
Zhang, W., Deng, B., Xie, F., Zhou, H., Guo, J., Jiang, H., Sim, A., Tang, B., & Wang, Q. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101589 · Cited by 118
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 108
Lopatina, O. L., Yoshihara, T., Nishimura, T., Zhong, J., Akther, S., Fakhrul, A. A. K. M., Liang, M., Higashida, C., Sumi, K., Furuhara, K., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00133 · Cited by 109
Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels
Shi, L., Bian, X., Qu, Z., Ma, Z., Zhou, Y., Wang, K., Jiang, H., & Xie, J. (2013) · Nature Communications · doi:10.1038/ncomms2439 · Cited by 103
Associations between sleep bruxism and other sleep-related disorders in adults: a systematic review
Kuang, B., Li, D., Lobbezoo, F., de Vries, R., Hilgevoord, A. A. J., de Vries, N., Huynh, N. T., Lavigne, G. J., & Aarab, G. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.11.008 · Cited by 106
Yang, W., Chen, Y., Liu, H., & Qu, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2356 · Cited by 105
Freezing beyond gait in Parkinson's disease: A review of current neurobehavioral evidence
Vercruysse, S., Gilat, M., Shine, J. M., Heremans, E., Lewis, S. J. G., & Nieuwboer, A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.04.010 · Cited by 104
Jones, C. K., Bubser, M., Thompson, A. D., Dickerson, J. W., Turle-Lorenzo, N., Amalric, M., Blobaum, A. L., Bridges, T. M., Morrison, R. D., Jadhav, S. B., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187443 · Cited by 104
Zhang, Q., Wang, Z., Zhang, J.-L., Duan, Y.-L., Li, G.-F., & Zheng, D.-L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.017 · Cited by 104
Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models
Maulik, M., Mitra, S., Bult‐Ito, A., Taylor, B. E., & Vayndorf, E. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00077 · Cited by 110
Ginkgetin: A natural biflavone with versatile pharmacological activities
Adnan, M., Rasul, A., Hussain, G., Shah, M. A., Zahoor, M. K., Anwar, H., Sarfraz, I., Riaz, A., Manzoor, M., Adem, Ş., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111642 · Cited by 102
Rivera, M. J., Teruel, M. Á., Maté, A., & Trujillo, J. C. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-09986-y · Cited by 116
Gillespie, R. J., Bamford, S. J., Botting, R., Comer, M., Denny, S., Gaur, S., Griffin, M., Jordan, A. M., Knight, A. R., Lerpiniere, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800961g · Cited by 104
El‐Hasnony, I. M., Barakat, S., & Mostafa, R. R. (2020) · IEEE Access · doi:10.1109/access.2020.3005614 · Cited by 103
Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity
Takahashi, R., Ono, K., Takamura, Y., Mizuguchi, M., Ikeda, T., Nishijo, H., & Yamada, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13180 · Cited by 106
Voiceprints analysis using MFCC and SVM for detecting patients with Parkinson's disease
Benba, A., Jilbab, A., Hammouch, A., & Sandabad, S. (2015) · International Conference on Electrical and Information Technologies · doi:10.1109/eitech.2015.7163000 · Cited by 102
“During its course, PD causes diverse symptoms and it influences the system which controls the execution of learned motor plans such as walking, talking or completing other simple tasks [1] [2] [3].”
DJ‐1 deficiency impairs autophagy and reduces alpha‐synuclein phagocytosis by microglia
Nash, Y., Schmukler, E., Trudler, D., Pinkas‐Kramarski, R., & Frenkel, D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14222 · Cited by 100
Patterson, J. R., Duffy, M. F., Kemp, C. J., Howe, J. W., Collier, T. J., Stoll, A. C., Miller, K. M., Patel, P., Levine, N. D., Moore, D. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104525 · Cited by 108
Quadriceps Muscle Weakness, Activation Deficits, and Fatigue With Parkinson Disease
Stevens‐Lapsley, J. E., Kluger, B. M., & Schenkman, M. L. (2011) · Neurorehabilitation and neural repair · doi:10.1177/1545968311425925 · Cited by 102
Duncan, R. P., & Earhart, G. M. (2010) · Disability and Rehabilitation · doi:10.3109/09638288.2010.533245 · Cited by 103
“The cardinal features of PD are rigidity, bradykinesia, tremor, and postural instability [2].”
BackgroundImaging of Motor Cortex Physiology in Parkinson's Disease
Burciu, R. G., & Vaillancourt, D. E. (2018) · Movement Disorders · doi:10.1002/mds.102 · Cited by 107
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102
Jin, X., Wang, L., Liu, S., Zhu, L., Loprinzi, P. D., & Fan, X. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010031 · Cited by 113
“With the degeneration of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies as pathological features [2], patients have gait and posture disorders, resting tremor, bradykinesia, muscle stiffness, and other characteristic motor symptoms [3]; accompanied by non-motor disorders such as sleep di…”
Shawen, N., O’Brien, M. K., Venkatesan, S., Lonini, L., Simuni, T., Hamilton, J. L., Ghaffari, R., Rogers, J. A., & Jayaraman, A. (2020) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-020-00684-4 · Cited by 102
“Bradykinesia is defined as slowness to voluntarily initiate movement, with decreasing speed and amplitude over time [23, 24].”
Subcortical Cognition: The Fruit Below the Rind
Janacsek, K., Evans, T. M., Kiss, M. M., Shah, L., Blumenfeld, H., & Ullman, M. T. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-013544 · Cited by 114
Zhen, K., Zhang, S., Tao, X., Li, G., Lv, Y., & Yu, L. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00418-4 · Cited by 112
Junaid, M., Ali, S., Eid, F., El–Sappagh, S., & Abuhmed, T. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107495 · Cited by 104
Mitochondrial dysfunction and Parkinson disease: a Parkin–AMPK alliance in neuroprotection
Hang, L., Thundyil, J., & Lim, K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12820 · Cited by 103
Cury, R. G., Galhardoni, R., Fonoff, E. T., Perez‐Lloret, S., Ghilardi, M. G. D. S., Barbosa, E. R., Teixeira, M. J., & de Andrade, D. C. (2015) · European Journal of Pain · doi:10.1002/ejp.745 · Cited by 100
Metadata
- Authors
- Jankovic, J.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jankovic, J
- ORCID
- Jankovic, J
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2008-04-01
- Volume
- 79
- Issue
- 4
- Pages
- 368-376
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2145954079
- Cited by
- 5,720
- References
- 157
- Citations by year
- 2026: 307 · 2025: 455 · 2024: 503 · 2023: 422 · 2022: 424 · 2021: 444 · 2020: 455 · 2019: 405 · 2018: 349 · 2017: 323 · 2016: 324 · 2015: 298 · 2014: 257 · 2013: 232 · 2012: 184
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Parkinson Foundation
- Parkinsonfonden
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, clinical features, diagnosis, parkinsonism, resting tremor, bradykinesia, rigidity, postural instability, non-motor symptoms, autonomic dysfunction, levodopa response, differential diagnosis, biomarkers, genetic mutations, neuroimaging
- MeSH terms
- Diagnosis, Differential, Humans, Neurologic Examination, Parkinson Disease, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
